Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Treatment Timing for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Lewes, Delaware
This trial compares giving standard therapy after surgery to giving standard therapy before and after surgery in patients with a specific type of lung cancer that can be removed by surgery. The goal is to determine which approach is
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service